Lifecore Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview

Lifecore Biomedical

01/04/2025 21:02

Lifecore Biomedical Inc LFCR.OQ LFCR.O is expected to report resultson April 3 for the period ending February 28 2025

The Chaska Minnesota-based  company is expected to report revenue of $33.229 million, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Lifecore Biomedical Inc is for a loss of 15 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Lifecore Biomedical Inc is $10.00​, above​ its last closing price of $7.04. ​​​

This summary was machine generated April 1 at 20:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)